TIGIT and acute myeloid leukemia: Here, we examined the association between immune checkpoint‐related gene (PD1, LAG3, TIM3, and TIGIT) polymorphisms and susceptibility, clinical variables, risk stratification, response to chemotherapy, relapse, and survival of AML.